Procedural Sedation
Procedural Sedation
What is Procedural Sedation?
A technique of administering sedative or dissociative agents with or without analgesics.
Allows patients to tolerate unpleasant procedures while maintaining cardiorespiratory function.
Results in a depressed level of consciousness while enabling patients to maintain independent oxygenation and airway control.
Levels of Sedation
Continuum of Sedation
Minimal Sedation
Drug-induced state with normal response to verbal commands.
Cognitive function and coordination may be impaired, but ventilatory and cardiovascular functions remain unaffected.
Moderate Sedation (Conscious Sedation)
Drug-induced depression where patients respond purposefully to verbal commands or light tactile stimulation.
No interventions are required to maintain patent airway; spontaneous ventilation is adequate.
Cardiovascular function is usually maintained.
Deep Sedation
Patients cannot be easily aroused but respond purposefully to repeated or painful stimulation.
Ability to maintain ventilatory function may be impaired; assistance in maintaining patent airway may be needed.
Spontaneous ventilation may be inadequate; cardiovascular function is usually maintained.
General Anesthesia
Loss of consciousness; patients are not arousable, even with painful stimulus.
Often requires assistance in maintaining airway; positive pressure ventilation may be necessary.
Cardiovascular function may be impaired.
Dissociative Sedation
A trance-like state with profound analgesia and amnesia while retaining airway reflexes.
Uses ketamine as the pharmacologic agent.
Visual Representation of Sedation Levels
Comparison of Levels of Sedation
Minimal Sedation: Normal response, unaffected airway.
Moderate Sedation: Purposeful response; adequate spontaneous ventilation.
Deep Sedation: Purposeful response after stimulation; may require intervention for airway maintenance.
General Anesthesia: No response; intervention required.
Ramsay Sedation Scale (RSS)
Score Responses
1: Anxious, restless, or both.
2: Cooperative, oriented, tranquil.
3: Responding to commands.
4: Brisk response to stimulus.
5: Sluggish response to stimulus.
6: No response.
RSS Levels
1, 2, 3 = Awake
4, 5, 6 = Asleep
Risks of Procedural Sedation
Airway and breathing adverse events.
Chemical sedation complications:
Oropharyngeal soft tissue collapse
Head/neck malpositioning
Laryngospasm
Hypoventilation and loss of airway reflexes
Hypoxia, airway secretions, assisted ventilation, gastric insufflation, aspiration
Goals of Procedural Sedation
Too Little Sedation:
Leads to patient discomfort and lack of cooperation.
Too Much Sedation:
Risks cardiac or respiratory depression.
Procedural Sedation Basics
Monitoring Goals
Patient safety is the priority.
Constant monitoring:
Patient's breathing, sedation, analgesia, and anxiolysis.
Minimize adverse psychological responses to pain.
Patient must return to a safe state for discharge.
Use of waveform capnography.
Pre-Procedural Checklist
Patient history and physical exam.
Obtain informed consent.
Ensure airway rescue equipment is prepared.
Administer medications appropriately.
Initial and Titration Doses
Midazolam: 1-2 mg IV; titrate as needed.
Fentanyl: 1-5 mcg/kg IV; titrate accordingly.
Propofol: 0.5-1 mg/kg IV; monitor closely.
Ketamine: 1-2 mg/kg IV, additional 0.5 mg/kg as necessary.
Equipment Required
CAS monitoring (ECG, NIBP, SpO2, EtCO2).
Supplemental Oxygen, self-inflating BVM.
Airway management tools (OPA, NPA, Laryngoscope, ETT, Supraglottic Airway).
Suction equipment.
Characteristics of an Ideal Agent for Procedural Sedation
Predictable onset and offset.
Wide therapeutic window with hemodynamic stability.
Minimally affects respiratory function; no significant side effects like nausea or vomiting.
Choice of Drug
Available agents include:
Benzodiazepines
Opioids
Hypnotics
Inhalational Anesthetics
Alpha-2 Agonists
Co-administration practices like "Ketofol."
Ketofol
Combination of Ketamine and Propofol (1:1 or 0.5:1).
Potential Advantages
Synergistic effects, lower doses required.
Balanced side effects for optimal patient comfort.
Potential Disadvantages
Limited evidence on benefits over monotherapy.
Alpha-2 Agonist: Dexmedetomidine (Precedex®)
Potent in brain and spinal cord with rapid distribution.
Potential Advantages
Sedation without respiratory depression.
Can be beneficial in managing shivering and delirium.
Potential Disadvantages
Possible bradycardia and hypotension; may cause dry mouth.
Monitoring for Procedural Sedation
Patient Monitoring
Ensure airway patency and protection.
Monitor oxygenation and ventilation.
Regularly assess hemodynamics.